Yes, there are multiple active class action lawsuits and settlements addressing hernia mesh adhesion and infection complications. As of March 2026, over 26,263 pending lawsuits are consolidated into four federal multidistrict litigations (MDLs), with tens of thousands of plaintiffs seeking compensation for serious medical injuries caused by defective hernia mesh implants. The litigation primarily targets major manufacturers including Bard, Covidien, and Atrium, with some cases already settling for hundreds of millions of dollars and individual compensation ranging from tens of thousands to hundreds of thousands of dollars depending on injury severity.
These cases stem from a critical design flaw: hernia mesh products intended to reinforce surgical repairs have instead caused patients to suffer adhesions (where the mesh breaks down and internal organs fuse together), severe infections, bowel obstructions, and chronic inflammation years after implantation. One patient implanted with a Covidien Symbotex device in January 2017 experienced adhesions, chronic inflammation, and bowel problems—complications that required additional surgeries and ongoing medical treatment. This pattern has repeated across thousands of patients, making hernia mesh litigation one of the most significant medical device cases in recent years.
Table of Contents
- What Are Hernia Mesh Adhesion and Infection Complications?
- The Current State of Hernia Mesh Litigation
- Settlement Amounts and Compensation Available
- Documented Medical Complications Linked to Defective Hernia Mesh
- Bellwether Trials and What They Mean for Pending Cases
- The Manufacturers and Their Settlement Status
- Filing a Claim or Joining a Class Action
- Conclusion
What Are Hernia Mesh Adhesion and Infection Complications?
Hernia mesh is a synthetic material surgically implanted to reinforce a weakened abdominal wall after hernia repair. Under normal circumstances, the mesh integrates with tissue and provides long-term support. However, defective hernia mesh products have failed to perform as intended, instead triggering a cascade of harmful complications. Adhesions occur when the mesh material breaks down or degrades, causing internal organs and tissue structures to abnormally fuse together. This can lead to severe pain, bowel obstruction, and the need for additional emergency surgeries.
Infections have also become commonplace, sometimes years after the initial implant surgery, even in patients who had no complications immediately following the procedure. The infection risk is particularly dangerous because it can become life-threatening if left untreated. Unlike infections acquired during surgery itself, mesh-related infections may develop months or years post-implant as the material degrades or as bacteria colonize the foreign object. These infections often require intensive antibiotic treatment or surgical mesh removal—itself a complex and risky procedure. A comparison: while traditional suture-based hernia repairs carry approximately 10–15% recurrence rates, defective mesh products have resulted in complications affecting roughly 15–30% of affected patients, a significantly higher burden of harm than the device was designed to address.
The Current State of Hernia Mesh Litigation
As of February 2026, hernia mesh litigation is consolidated across four federal MDLs: MDL #2782 in the Northern District of Georgia, MDL #2846 in the Southern District of Ohio, MDL #2753 in the District of New Hampshire, and MDL #3029 in the District of Massachusetts. These MDLs house 26,263 pending lawsuits, with the majority targeting bard (23,728 cases), followed by Covidien (2,260 cases) and Atrium (246 cases). This consolidation allows plaintiffs to share discovery, streamline pretrial proceedings, and resolve cases more efficiently than if each lawsuit were litigated separately.
The litigation remains active and ongoing, with no global resolution in sight for all defendants. While Ethicon, Bard, and Atrium have reached settlements, Covidien continues active litigation into 2026 and beyond. This means that plaintiffs injured by Covidien mesh products do not yet have a predetermined settlement pathway—their cases will be decided through bellwether trials and subsequent settlement negotiations. An important limitation: even settled cases often take 2–4 years from filing to final compensation, and pending cases in active litigation may take considerably longer to resolve, meaning injured patients must be prepared for extended waits before receiving compensation.
Settlement Amounts and Compensation Available
The most significant settlement to date involves Bard, which in October 2024 reached a settlement agreement potentially exceeding $1 billion, resolving nearly 40,000 claims. This represents the largest recovery in hernia mesh litigation and demonstrates the substantial liability manufacturers face. Atrium settled its C-Qur™ hernia mesh lawsuits in December 2021 for $66 million, compensating over 3,000 injured plaintiffs. These settlements provide a baseline for understanding what injured patients can expect.
For individual compensation, settlement and verdict amounts typically range from $65,000 to $80,000 for straightforward cases involving documented mesh-related complications. More complex cases—those involving multiple surgeries, chronic pain, bowel obstruction, or extended hospitalization—often result in awards between $60,000 and $100,000. The most severely injured patients, those suffering catastrophic complications such as permanent organ damage or requiring multiple revision surgeries, have received settlements and verdicts reaching several hundred thousand dollars. However, a critical caveat: these figures represent gross compensation before legal fees (typically 25–33%), medical liens, and case expenses, meaning the actual amount received by plaintiffs is typically 40–60% of the stated settlement or verdict.
Documented Medical Complications Linked to Defective Hernia Mesh
Patients injured by hernia mesh products have reported a consistent pattern of serious medical complications. Adhesions are among the most common, occurring when mesh material degrades and internal structures fuse together, causing severe abdominal pain and often requiring emergency surgery to separate the adhesions. Severe infections, including life-threatening bacterial colonization of the implant, have affected thousands of plaintiffs. Many patients have experienced bowel obstruction—a potentially fatal condition requiring immediate hospitalization and often emergency surgery to restore intestinal function. Organ tears caused by the mesh material itself or during removal procedures, chronic inflammation lasting months or years post-implant, and migration of the mesh away from the repair site have all been documented in medical literature and case records.
One illustrative example involves a plaintiff whose Covidien Symbotex mesh implant in January 2017 led to adhesions, chronic inflammation, and bowel problems within three years of surgery. This patient required multiple subsequent surgeries to address the complications and continues to experience chronic abdominal pain. This case is not isolated—it reflects a pattern affecting thousands of mesh recipients. The timing of complications varies; some appear within months of implantation, while others emerge years later as the mesh material continues to degrade. This delayed onset makes it difficult for patients to immediately connect their symptoms to the mesh implant, often resulting in misdiagnosis and unnecessary additional treatments before the true cause is identified.
Bellwether Trials and What They Mean for Pending Cases
Bellwether trials are test cases selected to represent the broader litigation. Their outcomes provide insight into how judges and juries view the evidence and help guide future settlement negotiations. In hernia mesh litigation, two bellwether trials are scheduled: the first began February 17, 2026, involving a Covidien Symbotex case, and the second is scheduled for July 13, 2026. These trials are critical because they involve the only remaining active defendant with substantial pending cases (Covidien), and their outcomes will likely determine whether Covidien settles its remaining docket or whether hundreds of cases proceed to individual trial.
The February 2026 bellwether case involves a plaintiff whose Covidien Symbotex device caused adhesions, chronic inflammation, and bowel problems, resulting in multiple surgeries and ongoing medical complications. The jury’s verdict in this case will signal whether Covidien faces significant liability exposure for the same pattern of complications documented in thousands of other cases. An important limitation: bellwether trials represent only a subset of cases and do not legally bind all other plaintiffs’ cases to the same outcome, though they typically carry substantial persuasive weight in settlement discussions. Defendants often use favorable verdicts to argue for lower settlement values, while plaintiffs leverage unfavorable verdicts to demand higher compensation.
The Manufacturers and Their Settlement Status
Three major manufacturers dominate hernia mesh litigation: Bard (C.R. Bard, Inc.), Covidien (acquired by Medtronic), and Atrium. Bard has already settled, as has Atrium. Ethicon, a Johnson & Johnson subsidiary, also faced significant hernia mesh litigation and has settled.
However, Covidien remains the only major manufacturer with substantial active litigation, with 2,260 pending cases as of February 2026. Covidien’s Symbotex mesh product is central to many pending lawsuits, and the company has not agreed to a global settlement despite the clear pattern of adhesions and infections documented across thousands of implants. Understanding which manufacturer produced your mesh implant is essential for determining which MDL your case belongs to and what settlement pathway is available. Patients injured by Bard products can pursue settlement claims through the Bard resolution process; Atrium patients similarly have access to the pre-existing Atrium settlement; but Covidien patients currently have no guaranteed settlement option and may need to proceed through individual litigation or await a Covidien settlement agreement following upcoming bellwether trials.
Filing a Claim or Joining a Class Action
To file a hernia mesh claim, you must first establish that you received a hernia mesh implant from one of the defendants (Bard, Covidien, Atrium, or Ethicon), that you developed documented complications consistent with mesh-related injury (adhesions, infection, bowel obstruction, organ damage, or chronic inflammation), and that there is a medical causal link between the mesh implant and your injuries. You will need surgical records documenting the implant date and type, medical records showing your subsequent complications, and evidence of the treatment and medical expenses you incurred.
Once you file, your case will be consolidated into one of the four federal MDLs based on where you file and the defendant involved. From there, the litigation process involves discovery (exchange of evidence between parties), motion practice, and potentially settlement negotiations. The timeline varies significantly: some settled cases resolve within 12–18 months of filing, while active litigation against Covidien may take 3–5 years or longer before resolution, depending on how many bellwether trials occur and how long settlement negotiations take.
Conclusion
Hernia mesh adhesion and infection complications represent one of the most significant ongoing medical device litigations in the United States. With over 26,000 pending lawsuits, settlements exceeding $1 billion, and individual compensation typically ranging from $65,000 to $80,000 (with higher awards for complex cases), injured patients have substantial legal remedies available. While Bard, Atrium, and Ethicon have settled, Covidien’s cases remain in active litigation with critical bellwether trials scheduled for 2026, meaning the landscape may shift significantly in the coming months.
If you received a hernia mesh implant and subsequently developed adhesions, infections, bowel obstruction, or chronic inflammation, consult with a medical device attorney to evaluate your case. Time-sensitive factors, including statutes of limitations and evolving settlement deadlines, make prompt action essential. Your medical records, implant documentation, and detailed history of complications are critical to establishing a strong claim and securing fair compensation for the harm caused by a defective medical device.